Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neupogen for Thin Endometrium or Recurrent Implantation Failure in ICSI
NCT03023774Completed
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Jun 2016
- Primary completion
- Oct 2016
- Modality
- Cytokines & Interferons
01
Overview
Randomised, open-label trial of filgrastim in thin endometrium and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: Endometrial thickness at 1 week. Started Jun 2016; status: completed.
02
Drugs
filgrastim
03
Conditions
thin endometriumRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03023774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023774.